The acidic precursor of CBD (cannabidiolic acid, CBDA) has been able to inhibit the migration of breast cancer cells and to downregulate the proto-oncogene c-fos and the cyclooxygenase-2 (COX-2), highlighting the possibility that CBDA might act on a common pathway of inflammation and cancer mechanisms [27]. This evidence concerns the gene PTGS2 and cancer.